PACS Group (PACS) Expected to Post Earnings on Tuesday

PACS Group (NYSE:PACSGet Free Report) is projected to announce its Q2 2026 resultson Tuesday, August 4th. Analysts expect PACS Group to post earnings of $0.55 per share and revenue of $1.4139 billion for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 11:30 AM ET.

PACS Group (NYSE:PACSGet Free Report) last posted its quarterly earnings data on Monday, May 11th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. PACS Group had a net margin of 4.49% and a return on equity of 26.47%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.36 billion. On average, analysts expect PACS Group to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

PACS Group Trading Down 1.0%

NYSE PACS opened at $46.48 on Thursday. The company’s fifty day simple moving average is $40.59 and its 200-day simple moving average is $37.54. PACS Group has a 52 week low of $7.50 and a 52 week high of $48.00. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.27. The stock has a market cap of $7.36 billion, a P/E ratio of 29.80, a PEG ratio of 1.40 and a beta of -0.08.

Insiders Place Their Bets

In other news, insider John Todd Mitchell sold 52,763 shares of the business’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $38.02, for a total value of $2,006,049.26. Following the completion of the sale, the insider owned 830,955 shares of the company’s stock, valued at approximately $31,592,909.10. The trade was a 5.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Mark Hancock sold 153,254 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $36.34, for a total transaction of $5,569,250.36. Following the completion of the sale, the insider owned 54,449,343 shares in the company, valued at approximately $1,978,689,124.62. This trade represents a 0.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 796,524 shares of company stock valued at $31,611,396 in the last ninety days. Corporate insiders own 70.10% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Cubist Systematic Strategies LLC acquired a new position in shares of PACS Group in the 1st quarter worth approximately $198,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in PACS Group by 6.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,280 shares of the company’s stock worth $262,000 after purchasing an additional 1,443 shares during the last quarter. Millennium Management LLC boosted its holdings in PACS Group by 68.3% in the first quarter. Millennium Management LLC now owns 859,295 shares of the company’s stock worth $9,658,000 after purchasing an additional 348,743 shares during the period. Jones Financial Companies Lllp bought a new stake in PACS Group during the first quarter valued at $64,000. Finally, Caxton Associates LLP bought a new stake in PACS Group during the first quarter valued at $163,000.

Wall Street Analysts Forecast Growth

PACS has been the subject of a number of recent analyst reports. Weiss Ratings raised shares of PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, July 8th. Oppenheimer boosted their price objective on shares of PACS Group from $42.00 to $48.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Wall Street Zen raised shares of PACS Group from a “buy” rating to a “strong-buy” rating in a research report on Monday, June 15th. UBS Group raised their target price on PACS Group from $50.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Finally, Truist Financial lifted their target price on PACS Group from $50.00 to $52.00 and gave the stock a “buy” rating in a research report on Monday, May 18th. Five analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, PACS Group has an average rating of “Moderate Buy” and a consensus target price of $50.60.

Get Our Latest Stock Analysis on PACS Group

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Recommended Stories

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.